For years, people thought that attention deficit hyperactivity disorder (ADHD) was a problem that only kids had. It was ...
Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...
Emotional outbursts and sudden mood shifts are part of various mental health conditions. Learn what drives this dysregulation ...
The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder ...
The hyperactivity disorder, usually referred to as ADHD, is an independent risk factor for several common and serious mental health issues, finds research published in the open access journal BMJ ...
Low" leaned intently over a glowing digital controller, headphones on and head bobbing, as she mixed two tracks by New Order ...
The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.
UK had highest relative increase of five countries in study, with 20-fold rise in proportion of women over 25 using it ...
Difficulty focusing isn’t always ADHD. Attention problems can stem from sleep, stress, mental health, or medical factors.
The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...
Hilton was diagnosed with ADHD as an adult, and although she struggled to cope with some of the symptoms as a teen, she now ...